Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle

Vaccine

Volumn 25, Issue 7, 2007, Pages 1167-1174

  Toussaint, J F ^a   Dubois, A ^a   Dispas, M ^a   Paquet, D ^a   Letellier, C ^a   Kerkhofs, P ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

Agarose; Cattle; DNA vaccine; Herpesvirus; Slow release

Indexed keywords

AGAROSE; BAYOVAC; DNA VACCINE; INACTIVATED VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANT; GENETIC IMMUNIZATION; HYDROGEL; IMMUNE RESPONSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; SLOW RELEASE FORMULATION; VACCINATION;

ANIMALS; CATTLE; CATTLE DISEASES; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG IMPLANTS; EXCIPIENTS; FECES; HERPESVIRUS 1, BOVINE; HYDROGELS; IMMUNIZATION; IMMUNIZATION SCHEDULE; INFLAMMATION; NEUTRALIZATION TESTS; OSMOTIC PRESSURE; PLASMIDS; SEPHAROSE; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 33845912420     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.021     Document Type: Article

References (41)

1. Babiuk L.A., Babiuk S.L., Loehr B.I., and van Drunen Littel-van den Hurk S. Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol 76 1-2 (2000) 1-23
2. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., and van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
3. Klinman D.M., Ishii K.J., and Verthelyi D. CpG DNA augments the immunogenicity of plasmid DNA vaccines. Curr Top Microbiol Immunol (2000) 247131-247142
4. van Rooij E.M., Glansbeek H.L., Hilgers L.A., te Lintelo E.G., de Visser Y.E., Boersma W.J., et al. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. J Virol 76 20 (2002) 10540-10545
5. Robinson H.L. Prime boost vaccines power up in people. Nat Med 9 6 (2003) 642-643
6. van Drunen Littel-van den Hurk S., Babiuk S.L., and Babiuk L.A. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. Immunol Rev (2004) 199113-199125
7. Braun R.P., Babiuk L.A., Loehr B.I., and van Drunen Littel-van den Hurk S. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology 265 1 (1999) 46-56
8. Babiuk S., Baca-Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20 27-28 (2002) 3399-3408
9. O'Hagan D.T., Singh M., and Ulmer J.B. Microparticles for the delivery of DNA vaccines. Immunol Rev (2004) 199191-199200
10. Tabata Y., and Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 22 10 (1988) 837-858
11. Tabata Y., and Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci (1990) 94107-94141
12. Denis-Mize K.S., Dupuis M., MacKichan M.L., Singh M., Doe B., O'Hagan D., et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 7 24 (2000) 2105-2112
13. Walter E., Moelling K., Pavlovic J., and Merkle H.P. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics. J Control Release 61 3 (1999) 361-374
14. Fooks A.R., Sharpe S.A., Shallcross J.A., Clegg J.C., and Cranage M.P. Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein. Dev Biol (Basel) (2000) 10465-10471
15. Theeuwes F., and Yum S.I. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4 4 (1976) 343-353
16. Zhu J., Zhang L., Hanisch U.K., Felgner P.L., and Reszka R. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Ther 3 6 (1996) 472-476
17. Duckworth M., and Yaphe W. Preparation of agarose by fractionation from the spectrum of polysaccharides in agar. Anal Biochem 44 2 (1971) 636-641
18. Upcroft P., and Upcroft J.A. Comparison of properties of agarose for electrophoresis of DNA. J Chromatogr 618 1-2 (1993) 79-93
19. Maaloum M., Pernodet N., and Tinland B. Agarose gel structure using atomic force microscopy:gel concentration and ionic strength effects. Electrophoresis 3 10 (2000) 1606-1610
20. Meilander-Lin N.J., Cheung P.J., Wilson D.L., and Bellamkonda R.V. Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 11 3-4 (2005) 546-555
21. Meilander N.J., Pasumarthy M.K., Kowalczyk T.H., Cooper M.J., and Bellamkonda R.V. Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel. J Control Release 88 2 (2003) 321-331
22. Ohgawara H. Strategies for immunoisolation in islet transplantation: challenges for the twenty-first century. J Hepatobiliary Pancreat Surg 7 4 (2000) 374-379
23. Uludag H., De Vos P., and Tresco P.A. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 42 1-2 (2000) 29-64
24. Rahfoth B., Weisser J., Sternkopf F., Aigner T., von der Mark K., and Brauer R. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthritis Cartilage 6 1 (1998) 50-65
25. Tikoo S.K., Campos M., and Babiuk L.A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res (1995) 45191-45223
26. van Oirschot J.T., Kaashoek M.J., and Rijsewijk F.A. Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet Microbiol 53 1-2 (1996) 43-54
27. van Oirschot J.T., Kaashoek M.J., Maris-Veldhuis M.A., Weerdmeester K., and Rijsewijk F.A. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J Virol Methods 67 1 (1997) 23-34
28. Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A., Quak J., Gielkens A.L., et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12 5 (1994) 439-444
29. Kaashoek M.J., Moerman A., Madic J., Weerdmeester K., Maris-Veldhuis M., Rijsewijk F.A., et al. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13 4 (1995) 342-346
30. Bosch J.C., Kaashoek M.J., Kroese A.H., and van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet Microbiol 52 3-4 (1996) 223-234
31. Bosch J.C., Kaashoek M.J., and van Oirschot J.T. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine (1997) 151512-151517
32. Kerkhofs P., Renjifo X., Toussaint J.F., Letellier C., Vanopdenbosch E., and Wellemans G. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine. Vet Rec 152 22 (2003) 681-686
33. Gupta P.K., Saini M., Gupta L.K., Rao V.D., Bandyopadhyay S.K., Butchaiah G., et al. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet Microbiol 78 4 (2001) 293-305
34. Castrucci G., Frigeri F., Salvatori D., Ferrari M., Dico M.L., Rotola A., et al. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection. Comp Immunol Microbiol Infect Dis 25 4 (2002) 205-215
35. Toussaint J.F., Coen L., Letellier C., Dispas M., Gillet L., Vanderplasschen A., et al. Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8. Vet Res 36 4 (2005) 529-544
36. Toussaint J.F., Letellier C., Paquet D., Dispas M., and Kerkhofs P. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1. Vaccine 23 43 (2005) 5073-5081
37. Kaashoek M.J., Straver P.H., van Rooij E.M., Quak J., and van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects. Vet Rec 139 17 (1996) 416-421
38. Skinner J.G., and Roberts L. Haptoglobin as an indicator of infection in sheep. Vet Rec 134 2 (1994) 33-36
39. Humblet M.F., Coghe J., Lekeux P., and Godeau J.M. Acute phase proteins assessment for an early selection of treatments in growing calves suffering from bronchopneumonia under field conditions. Res Vet Sci 77 1 (2004) 41-47
40. Aucouturier J., Dupuis L., Deville S., Ascarateil S., and Ganne V. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vacc 1 1 (2002) 111-118
41. Scheffler J.M., Buskirk D.D., Rust S.R., Cowley J.D., and Doumit M.E. Effect of repeated administration of combination trenbolone acetate and estradiol implants on growth, carcass traits, and beef quality of long-fed Holstein steers. J Anim Sci 81 10 (2003) 2395-2400